|
|
|
|
|
By AR Welch, Editorial & Community Director, Advancing RNA | During a panel discussion last November, three CDMO execs shared the biggest scientific, regulatory, and technological complexities barring a “magical” solution to each biotech’s wishes. However, as each of the AMM panelists pointed out, there are short- and long-term technological innovations in the works that will be essential in advancing the manufacturing infrastructure for mRNA therapeutics in all their shapes, forms, and scales. | |
|
|
|
Three Advancing RNA Live panelists share their greatest needs in outsourcing partnerships for mRNA/RNA-LNP products and where sponsors should be the most prescriptive when drafting an MSA with an outsourcing partner. |
|
|
|
|
| Effects Of mRNA Capping Technologies | Poster | By C. Cobaugh, et. al., Vernal Biosciences | This study compares two important mRNA capping technologies by evaluating the mRNA integrity, percent Cap1 content, dsRNA content, in vivo expression, and innate immune activation in mice. |
|
|
|
| Building Local Biomanufacturing Capacity In South Africa | White Paper | By Jennifer Brant and David Marion, MilliporeSigma | Biovac evolved from a vaccine supplier to a biopharmaceutical innovator, providing a blueprint for expanding Africa's vaccine manufacturing capacity. Gain valuable insights from their journey. |
|
|
|
|
| High-Sensitivity IVT mRNA Analysis | Application Note | Agilent Technologies | Quality analysis of in vitro transcribed (IVT) has become an essential part of biotherapeutic workflows. Discover a high-sensitivity kit made for analyzing IVT mRNA quality to advance your research. |
|
|
|
| 4th In Vivo Cell Engineering & Gene Editing Summit | June 3-5, 2025 | Boston, MA
Join the 4th In Vivo Cell Engineering & Gene Editing Summit, the premier event advancing in vivo cell and gene therapies from research to clinic. Gain exclusive insights into IND-enabling data, regulatory pathways, next-gen delivery, and breakthrough innovations. Hear from leaders like Capstan, Editas, AbbVie & more to stay ahead in oncology, genetic, and rare disease therapies. Learn more. |
|
|
.png){kind=logo}
